TABLE 3.
Serum potassium levels with treatment
| Mean ± SD | Hypokalemia (< 3.5 mEq/L) | Potassium supplementation (≤ 3.7 mEq/L) | |
|---|---|---|---|
| Baseline | 4.03 ± .22 | ||
| ASA | 4.04 ± .21 | 0 | 2 (6%) |
| CTD | 3.64 ± .36* | 10 (30%) | 18 (53%) |
| HCTZ | 3.72 ± .27* | 6 (18%) | 17 (50%) |
*p < .001 for baseline to on‐treatment; difference in mean CTD versus HCTZ, p = .287.
Hypokalemia (K < 3.5): CTD versus ASA p < .001; HCTZ versus ASA p = .025; CTD versus HCTZ p = .392.
K+ supplementation: ASA versus CTD p < .001; HCTZ versus ASA p = .001; CTD versus HCTZ p = 1.00.